Projects funded by the NCN
Photoswitchable and chimeric molecules for spatially restricted and endoplasmic reticulum-specific blockade of PD-L1 protein
2021/42/E/NZ7/00422
Keywords:
immunotherapy immune checkpoint PD-1 PD-L1 photoswitch chimeric compound colorectal carcinoma
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ1_7: Cell engineering
- NZ5_7: Human disease treatment
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński, Wydział Chemii
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 9
Call: SONATA BIS 11 - announced on 2021-06-15
Amount awarded: 3 488 590 PLN
Project start date (Y-m-d): 2022-04-25
Project end date (Y-m-d): 2027-04-24
Project duration:: 60 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.